NTRA Stock Analysis: Buy, Sell, or Hold?
NTRA - Natera, Inc. Common Stock
$263.32
28.56 (12.17%)
▲
5d:
+19.63%
30d:
+29.59%
90d:
+35.37%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.6/10
Get Alerted When NTRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NTRA is 14.6% above its trading range ($229.87). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NTRA is 14.6% above its trading range ($229.87). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NTRA is currently trading at $263.32, which is considered extended relative to its 30-day fair value range of $202.79 to $229.87.
Technical Outlook: Technically, NTRA is showing sideways momentum. The price is approaching resistance at $261.24. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 12.2% recently.
Market Sentiment: NTRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $260.05 (+10.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTRA is showing sideways momentum. The price is approaching resistance at $261.24. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 12.2% recently.
Market Sentiment: NTRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $260.05 (+10.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$202.79 -
$229.87
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
NTRA is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.2%)
- BULLISH: Trading below Wall St target ($260.05)
Trading Range Analysis
30-Day Trading Range
$202.79 -
$229.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$208.79
Resistance Level
$261.24
Current Trend
Sideways
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1126.49
Wall Street Target
$260.05
(+10.8%)
Revenue Growth (YoY)
38.8%
Profit Margin
-9.0%
Share & Embed Analysis
Last updated: June 24, 2026 2:48 PM ET
Data refreshes hourly during market hours. Next update: 3:48 PM
Data refreshes hourly during market hours. Next update: 3:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Solomon Moshkevich
SELL
3000 shares
2026-04-01
Rowan E Chapman
SELL
122 shares
2026-03-13
John Fesko
SELL
707 shares
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 62 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 66 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$310 | 62 BUY |
Advanced NTRA Option Strategies
Professional options setups generated by AI based on today's NTRA price and gamma walls.
